Tryp Therapeutics Inc (TRYP) Corporate Media Kit

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), founded in 2019, is a San Diego-based pharmaceutical company focused on developing psychedelic com- pounds targeting diseases with high unmet medical needs using proprietary formulations. Tryp is in the process of advancing its drug development pipeline under its Psilocybin-for-Neuropsychiatric Disorders (PFN™) program for two types of disease: Chronic pain including fibromyalgia, phantom limb pain, complex regional pain syndrome, and others Eating disorders including binge eating disorder, hypothalamic obesity, and others